IOF Accelerator: Camelidae-derived single domain antibody fragments for theranosis of cancer

Project Details

Description

The accelerator budget will be invested in the development of an automated synthesis procedure for 18F labeled sdAbs in a GMP compliant procedure to allow clinical trials using PET/CT. At VUB we develop a pipeline of sdAb based diagnostics for imaging cancer cells and immune cell in the tumor microenvironment. The investment will accelerate the clinical translation of these imaging drugs.
AcronymIOFACC4
StatusActive
Effective start/end date21/12/1820/12/21

Flemish discipline codes

  • Cancer therapy

Keywords

  • automated synthesis
  • clinical trials